Most Read Articles
12 Aug 2019
Treatment with nebivolol yields more favourable changes in 24-hour, intradialytic and daytime systolic and diastolic blood pressure variability in patients with intradialytic hypertension, a study has found.
Stephen Padilla, 25 Jul 2019
Nonvitamin K antagonist oral anticoagulants (NOACs) appear to confer more clinical benefits to elderly patients with atrial fibrillation (AF) than vitamin K antagonist anticoagulants (VKAs), suggests a study, adding that this is primarily driven by the lower rates of major bleeding.
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
25 Jul 2019
Adding a third drug to achieve the target blood pressure (BP) seems to be more effective than increasing the dose of existing dual therapy without any increase in adverse events, suggest the results of a meta-analysis, adding that early use of triple therapy can help improve hypertension control.

Community-based on par with hospital-based intensive cardiac rehabilitation programme

12 Sep 2018

A 12-week community-based intensive cardiac rehabilitation programme results in significant positive changes in several measures of cardiac risk, with only one adverse event, a recent study has shown.

Individuals seeking either primary or secondary coronary artery disease prevention voluntarily enrolled in the 12-week intensive cardiac rehabilitation programme. The authors obtained data at baseline and 6–12 months after programme completion.

Of the 142 participants (mean age 69 years) who completed the Heart Series between 2012 and 2016, 105 (74 percent) had available follow-up data.

There were statistically significant improvements in mean weight (165–162 lbs; p=0.0005), body mass index (26–25 kg/m2; p=0.001), systolic blood pressure (126–122 mm Hg; p=0.01), diastolic blood pressure (73–70 mm Hg; p=0.0005), total cholesterol (175–168 mg/dL; p=0.03), low-density lipoprotein cholesterol (LDL-C; 100–93 mg/dL; p=0.005), LDL-C/high-density lipoprotein cholesterol (HDL-C) ratio (1.8–1.6; p=0.005), and cholesterol/HDL-C ratio (3.2–3.0; p=0.003).

Although changes in HDL-C, triglycerides and fasting blood glucose did not reach statistical significance, all trended in favourable directions. Furthermore, there were rare adverse cardiovascular disease outcomes (one stent placement; no deaths).

“These results compare favourably with those of hospital-based and academic institutional programmes,” the authors said.

In a previous 3-month, multifactorial cardiac rehabilitation programme that incorporated exercise training, risk factor modification, education and psychosocial support, researchers found that the minority of cardiac rehabilitation patients were women. However, they appeared to benefit equally well from the programme. [Can J Cardiol 2000;16:319-325]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
12 Aug 2019
Treatment with nebivolol yields more favourable changes in 24-hour, intradialytic and daytime systolic and diastolic blood pressure variability in patients with intradialytic hypertension, a study has found.
Stephen Padilla, 25 Jul 2019
Nonvitamin K antagonist oral anticoagulants (NOACs) appear to confer more clinical benefits to elderly patients with atrial fibrillation (AF) than vitamin K antagonist anticoagulants (VKAs), suggests a study, adding that this is primarily driven by the lower rates of major bleeding.
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
25 Jul 2019
Adding a third drug to achieve the target blood pressure (BP) seems to be more effective than increasing the dose of existing dual therapy without any increase in adverse events, suggest the results of a meta-analysis, adding that early use of triple therapy can help improve hypertension control.